Which drug contraindicate in hypertensive patients? & x20; - NORCET 2 -2021 (Shift-2)

NORCET 2 -2021 (Shift-2)

Pharmacology

Easy

Appeared in: NORCET 2 -2021 (Shift-2)

Explanation

Combined Oral Contraceptives (OCPs), which contain estrogen, are contraindicated in patients with hypertension due to an increased risk of adverse cardiovascular events.
The estrogen component stimulates the liver to produce more angiotensinogen, which activates the Renin-Angiotensin-Aldosterone System (RAAS), leading to vasoconstriction and fluid retention, thereby increasing blood pressure.
According to pharmacology principles, the use of COCs in hypertensive women significantly elevates the risk of myocardial infarction, stroke, and thromboembolism.

Option B: Labetalol is an antihypertensive medication used to lower blood pressure.
Option C: Progesterone-only pills (POPs) are a safer contraceptive alternative for women with hypertension because they lack the estrogen component that raises blood pressure.
Option D: Levonorgestrel (LNG) is a progestin used in hormonal IUDs and some pills. Progestin-only methods are preferred over combined pills for hypertensive patients.

Visual 1: Flowchart: Illustrating the mechanism of how estrogen in OCPs affects the Renin-Angiotensin-Aldosterone System (RAAS) to increase blood pressure.
Visual 2: Table: Comparing the safety and US Medical Eligibility Criteria (MEC) categories of various contraceptive methods (Combined OCPs, Progestin-only pills, IUDs) in patients with hypertension.

Clinical Relevance

Nursing practice connection: Knowing Contraindications of Oral Contraceptives in Hypertension helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
Nurses must perform a thorough health assessment, including accurate blood pressure measurement and smoking history, before administering or educating a patient about hormonal contraceptives.
Patient education is critical. Women on combined hormonal contraceptives should be taught the warning signs of cardiovascular complications (e.g., severe headache, chest pain, shortness of breath, vision changes, severe leg pain) and instructed to seek immediate medical attention if they occur.
What if the patient had well-controlled hypertension? The decision becomes more nuanced. For well-controlled hypertension, COCs are typically a Category 3 risk (risks generally outweigh benefits), and the decision requires careful clinical judgment. For uncontrolled or severe hypertension (e.g., greater than 160/100 mmHg), they are a Category 4 risk (unacceptable health risk).

How to Approach the Question

First, identify the core question: which drug is unsafe for a person with high blood pressure?
Next, analyze each option's drug class and primary function. OCPs are hormonal contraceptives, Labetalol is an antihypertensive, and Progesterone-only pills/LNG are specific types of hormonal contraceptives.
Recall the major contraindications for common drug classes. Remember that estrogen-containing contraceptives are strongly linked to cardiovascular risks, including worsening hypertension.
Evaluate Labetalol. Its purpose is to treat hypertension, making it the opposite of a contraindication.
Differentiate between combined OCPs (estrogen + progestin) and progestin-only methods. Progestin-only methods are widely recognized as safer alternatives when estrogen is contraindicated.
Conclude that OCPs, which generally implies the combined estrogen-progestin formulation, are the contraindicated drug class among the choices for a hypertensive patient.

Concept Tested & Keywords

Q6rIii_EsTWDYbUT_-3QGb